BMC Public Health,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Aug. 15, 2024
Parkinson's
disease
(PD)
is
a
neurodegenerative
influenced
by
various
clinical
factors.
The
potential
relationship
between
renal
function
and
the
risk
of
PD
remains
poorly
understood.
This
study
aims
to
explore
association
kidney
developing
PD.
Blood Purification,
Journal Year:
2024,
Volume and Issue:
53(10), P. 824 - 837
Published: Aug. 7, 2024
Introduction:
Uremic
patients
exhibit
remarkably
increased
rates
of
mortality
and
cardiovascular
(CV)
events,
but
risk
prediction
in
this
setting
remains
difficult.
Systemic
mitochondrial
dysfunction
is
pervasive
end-stage
kidney
disease
may
contribute
to
CV
complications.
We
tested
the
clinical
significance
circulating
MOTS-c,
a
small
mitochondrial-derived
peptide,
as
biomarker
for
improving
hemodialysis
(HD)
patients.
Methods:
conducted
prospective,
observational,
multicenter
study
on
94
prevalent
HD
The
endpoint
was
composite
all-cause
non-fatal
events.
diagnostic
prognostic
capacities
predictive
models
based
cohort-related
factors
were
before
after
inclusion
MOTS-c.
Results:
MOTS-c
levels
higher
than
controls
(p
<
0.001)
even
more
elevated
=
0.01)
53
individuals
experiencing
combined
during
follow-up
(median
duration:
26.5
months).
independently
associated
with
at
either
multivariate
logistic
(OR
1.020;
95%
CI:
1.011–1.109;
p
0.03)
or
Cox
regression
analyses
(HR
1.004;
1.000–1.025;
0.05)
addition
including
other
predictors
(age,
left
ventricular
mass,
evidence
diastolic
dysfunction,
diabetes,
pulse
pressure)
significantly
improved
calibration,
variability
explanation,
discrimination
(receiver
operating
characteristic
area
under
curve
from
0.727
0.743;
C-index
0.658
0.700),
particularly,
overall
reclassification
capacity
(NRI
15.87%;
0.01).
Conclusions:
In
patients,
peptide
impart
significant
information
refine
prediction,
beyond
factors.
Future
investigations
are
needed
generalize
these
findings
larger
heterogeneous
cohorts.
Mitochondrial Communications,
Journal Year:
2024,
Volume and Issue:
2, P. 21 - 37
Published: Jan. 1, 2024
Kidney
diseases
are
a
growing
health
problem
worldwide,
causing
millions
of
deaths.
Acute
kidney
injury
(AKI)
commonly
evolves
into
chronic
disease
(CKD)
and
fibrosis,
which
is
feature
CKD
predisposing
to
end-stage
renal
disease.
Thus,
treatments
that
avoid
this
transition
urgently
necessary.
Mitochondria
the
hub
energy
house
cells,
provides
in
adenosine
triphosphate
(ATP)
form,
obtained
from
β-oxidation
through
fatty
acids
degradation
mitochondrial
matrix.
plastic
organelles
constantly
change
according
cell's
requirements.
For
this,
mitochondria
carry
out
biogenesis,
fission,
fusion,
mitophagy/autophagy,
processes
highly
regulated
maintain
bioenergetics
homeostasis.
Alterations
one
or
more
these
might
cause
detrimental
consequences
affect
cell
function.
In
sense,
it
widely
accepted
dysfunction
associated
with
oxidative
stress
plays
crucial
role
developing
diseases.
Therefore,
antioxidants
target
be
an
excellent
strategy
ameliorate
dysfunction,
selecting
another
antioxidant
could
depend
on
AKI
This
review
focuses
potent
such
as
sulforaphane
(SFN),
N-acetyl
cysteine
(NAC),
resveratrol,
curcumin,
quercetin,
α-mangostin
improvement
function
pathologies.
BMC Public Health,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Aug. 15, 2024
Parkinson's
disease
(PD)
is
a
neurodegenerative
influenced
by
various
clinical
factors.
The
potential
relationship
between
renal
function
and
the
risk
of
PD
remains
poorly
understood.
This
study
aims
to
explore
association
kidney
developing
PD.